A detailed history of Dark Forest Capital Management LP transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Dark Forest Capital Management LP holds 36,535 shares of NTLA stock, worth $910,086. This represents 0.01% of its overall portfolio holdings.

Number of Shares
36,535
Holding current value
$910,086
% of portfolio
0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$6.28 - $9.67 $229,439 - $353,293
36,535 New
36,535 $342,000
Q2 2022

Aug 15, 2022

BUY
$38.49 - $76.21 $423 - $838
11 New
11 $1,000
Q1 2022

May 13, 2022

SELL
$58.27 - $118.99 $3,554 - $7,258
-61 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$100.76 - $138.36 $43,326 - $59,494
-430 Reduced 87.58%
61 $7,000
Q3 2021

Nov 12, 2021

BUY
$132.37 - $176.78 $64,993 - $86,798
491 New
491 $66,000

Others Institutions Holding NTLA

About Intellia Therapeutics, Inc.


  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $1.89B
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Dark Forest Capital Management LP Portfolio

Follow Dark Forest Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Dark Forest Capital Management LP with notifications on news.